ICU下呼吸道合并感染:支气管肺泡灌洗液微生物分析检出合并感染的患病率与临床意义及侵入性方法比较
该单中心回顾性观察研究纳入2012年8月1日至2018年1月1日ICU内803例接受BAL检查的机械通气成人患者,比较支气管镜与非支气管镜BAL的微生物学检出及临床结局。支气管镜BAL合并感染检出率高于非支气管镜BAL(26% vs 9%;p<0.001),病毒检出率更高(42% vs 13%;p<0.001),而非支气管镜BAL细菌检出率更高(42% vs 33%;p=0.011)。BAL分离病原体数为0、1、>2个者30天死亡率分别为43%、48%、58%(p=0.003);检出病毒与30天死亡率升高相关(56% vs 46%;p=0.033)。作者认为需前瞻性数据直接比较两种方法以制定标准化方案。
要点
- 支气管镜BAL合并感染检出率26%,高于非支气管镜BAL的9%(p<0.001)。
- 支气管镜BAL病毒检出率42%,高于非支气管镜BAL的13%(p<0.001);非支气管镜BAL细菌检出率42%,高于支气管镜BAL的33%(p=0.011)。
- BAL分离0、1、>2个病原体者30天死亡率分别为43%、48%、58%(p=0.003)。
- BAL检出病毒者30天死亡率56%,未检出病毒者46%(p=0.033)。
- 作者认为需前瞻性数据直接比较支气管镜与非支气管镜BAL,以制定不同患者群的标准化方案。
适用人群与场景
- ICU住院期间接受BAL检查的机械通气成人患者;单中心2012年8月1日至2018年1月1日ICU收治。
研究设计与关键结果
- 研究类型:回顾性观察研究;单中心ICU;2012年8月1日至2018年1月1日;纳入803例接受BAL检查的机械通气成人患者;无干预。
- 支气管镜BAL合并感染检出率26%,非支气管镜BAL为9%(p<0.001)。
- 支气管镜BAL病毒检出率42%,非支气管镜BAL为13%(p<0.001);非支气管镜BAL细菌检出率42%,支气管镜BAL为33%(p=0.011)。
- BAL分离0、1、>2个病原体者30天死亡率分别为43%、48%、58%(p=0.003)。
- BAL检出病毒者30天死亡率56%,未检出病毒者46%(p=0.033)。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需前瞻性数据直接比较支气管镜与非支气管镜BAL两种方法,以制定不同患者群的标准化方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Pneumonia remains a significant cause of morbidity and mortality, with increasing interest in the detection and clinical significance of coinfection. Further investigation into the impact of bronchoalveolar lavage (BAL) sampling methodology and efficient clinical utilization of microbiological analyses is needed to guide the management of lower respiratory tract infection in the ICU.
DESIGN: Retrospective observational study.
SETTING: ICUs at a single center between August 1, 2012, and January 1, 2018.
PATIENTS: Mechanically ventilated adult patients who underwent BAL testing during an ICU admission were included.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: BAL methodology (bronchoscopic vs nonbronchoscopic), microbiological diagnostic testing, and clinical outcomes measures were obtained. Chi-square or Fisher exact tests assessed associations between categorical variables, whereas Kruskal-Wallis tests analyzed differences in distributions of measures. BAL samples from 803 patients met inclusion criteria. Coinfection was detected more frequently via bronchoscopic BAL compared with nonbronchoscopic BAL (26% vs 9%; p < 0.001). Viruses were detected more frequently in bronchoscopic (42% vs 13%; p < 0.001) and bacteria in nonbronchoscopic (42% vs 33%; p = 0.011) BALs. A positive correlation between mortality and the number of organisms isolated was identified, with 43%, 48%, and 58% 30-day mortality among those with 0, 1, and more than 2 organisms, respectively (p = 0.003). Viral organism detection was associated with increased 30-day mortality (56% vs 46%; p = 0.033).
CONCLUSIONS: Even in the setting of standardized institutional techniques, retrospective evaluation of bronchoscopic and nonbronchoscopic BAL methodologies did not reveal similar microbiologic yield in critically ill patients, though bronchoscopic BAL overall yielded more organisms, and occurrence of multiple organisms in BAL was associated with worse outcome. Prospective data are needed for direct comparison of both methods to develop more standardized approaches for use in different patient groups.
参考来源
- Zelus CS, Blaha MA, Samson KK, et al. Lower Respiratory Tract Coinfection in the ICU: Prevalence and Clinical Significance of Coinfection Detected via Microbiological Analysis of Bronchoalveolar Lavage Fluid With a Comparison of Invasive Methodologies. Crit Care Explor. 2022. PMID: 35765376. doi:10.1097/CCE.0000000000000708
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。